Eaton Vance Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $41.8M | Buy |
|
|||||
|
2022
Q2 | $35.7M | Buy |
|
|||||
|
2022
Q1 | $40M | Buy |
|
|||||
|
2021
Q4 | $19.8M | Buy |
|
|||||
|
2021
Q3 | $18.5M | Buy |
|
|||||
|
2021
Q2 | $16.4M | Buy |
|
|||||
|
2021
Q1 | $13.7M | Buy |
|
|||||
|
2020
Q4 | $13.9M | Sell |
|
|||||
|
2020
Q3 | $16.7M | Buy |
|
|||||
|
2020
Q2 | $17.5M | Buy |
|
|||||
|
2020
Q1 | $12.7M | Buy |
|
|||||
|
2019
Q4 | $9.75M | Buy |
|
|||||
|
2019
Q3 | $6.09M | Buy |
|
|||||
|
2019
Q2 | $6.87M | Sell |
|
|||||
|
2019
Q1 | $9.59M | Sell |
|
|||||
|
2018
Q4 | $8.73M | Sell |
|
|||||
|
2018
Q3 | $9.52M | Hold |
|
|||||
|
2018
Q2 | $8.13M | Sell |
|
|||||
|
2018
Q1 | $40.7M | Buy |
|
|||||
|
2017
Q4 | $23.9M | Buy |
|
|||||
|
2017
Q3 | $26.1M | Buy |
|
|||||
|
2017
Q2 | $27.9M | Buy |
|
|||||
|
2017
Q1 | $18.2M | Sell |
|
|||||
|
2016
Q4 | $25.1M | Buy |
|
|||||
|
2016
Q3 | $25.7M | Sell |
|
|||||
|
2016
Q2 | $39M | Buy |
|
|||||
|
2016
Q1 | $1.53M | Sell |
|
|||||
|
2015
Q4 | $2.33M | Sell |
|
|||||
|
2015
Q3 | $2.31M | Buy |
|
|||||
|
2015
Q2 | $2.4M | Buy |
|
|||||
|
2015
Q1 | $2.04M | Buy |
|